爱尔眼科年报、一季报双增，创新驱动夯实长期增长潜力

Core Insights - Aier Eye Hospital focuses on core business and strengthens discipline construction, achieving steady growth in operating performance, outpatient visits, and surgical volume [1][2] Financial Performance - In 2024, the company reported operating revenue of 20.983 billion yuan, a year-on-year increase of 3.02% - The net profit attributable to the parent company was 3.556 billion yuan, up 5.87% - The company plans to distribute a cash dividend of 1.6 yuan per 10 shares, totaling approximately 1.487 billion yuan [1][12] Operational Growth - Outpatient visits reached 16.9407 million, a 12.14% increase year-on-year - Surgical volume was 1.2947 million cases, reflecting a 9.38% growth [2] Strategic Development - The "1+8+N" strategic layout has made significant progress, with multiple regional eye centers established [3][4] - By the end of 2024, the company operated 352 hospitals and 229 outpatient departments, highlighting its chain scale advantage [5] Quality Improvement - The company has enhanced medical quality and service levels, implementing comprehensive quality improvement actions and risk management [6] - Patient satisfaction rates are high, with an overall satisfaction rate of nearly 99.0% from over 1.6 million surveys conducted [7] Digital Transformation - Aier Eye Hospital has made significant advancements in digital ophthalmology and AI applications, establishing a competitive edge [8] - The company launched the AierGPT model and the digital human "Eyecho" in 2024 [9][10] Research and Development - The company is expanding its specialty areas, including ocular tumors and neuro-ophthalmology, while enhancing its research capabilities [11] - A total of 73 research projects were approved in 2024, with 5 at the national level, and 161 papers published, including 103 in SCI/Medline journals [11] Shareholder Returns - The company has consistently prioritized shareholder returns, with a cumulative dividend payout of 7.12 billion yuan since its listing [12][13] - Aier Eye Hospital has also implemented share buyback programs to stabilize stock prices and boost investor confidence [13] Social Responsibility - The company actively engages in social responsibility initiatives, including eye health poverty alleviation and community outreach programs [14] - In 2024, Aier Eye Hospital donated 217 million yuan to various public welfare projects, supporting 873 initiatives nationwide [14]